Position in GPCR
as of Mar 31, 2026
· filed Apr 29, 2026
Position Value
$18,885,193
+$463,555 QoQ
Shares Held
391,809
+47.9% QoQ
Ownership
0.184%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GPCR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Aberdeen Group plc holds $1,803,580,461 across 84 Biotechnology names. GPCR ranks #33 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
233,480 | $104,258,157 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
121,344 | $93,755,226 | |
| 3 | IMUX |
Immunic, Inc.
|
8,243,941 | $91,507,745 | |
| 4 | QURE |
uniQure N.V.
|
5,306,386 | $86,759,411 | |
| 5 | MANE |
Veradermics, Inc
|
1,054,660 | $66,601,779 | |
| 6 | ARGX |
Argenx SE
|
82,106 | $59,957,906 | |
| 7 | PCVX |
Vaxcyte, Inc.
|
978,969 | $56,887,888 | |
| 8 | PRAX |
Praxis Precision Medicines, Inc.
|
172,484 | $55,572,619 |
All Filings in GPCR
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $18,885,193 | 391,809 | Shares | Defined | 2026-04-29 | |
| 2025-12-31 | $18,421,638 | 264,869 | Shares | Defined | 2026-01-16 | |
| 2025-09-30 | $16,432,332 | 586,869 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $8,329,681 | 401,624 | Shares | Defined | 2025-07-24 | |
| 2025-03-31 | $4,308,441 | 248,899 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $4,648,042 | 171,388 | Shares | Defined | 2025-01-24 | |
| 2024-09-30 | $9,527,772 | 217,083 | Shares | Defined | 2024-10-25 | |
| 2024-06-30 | $3,663,655 | 93,294 | Shares | Defined | 2024-08-09 | |
| No filing history on record for this holder in this stock. | ||||||